Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07296939 · ClinicalTrials.gov registry record · NA

Youth Emotional and Behavioral Treatment Study

A NA study of Depression, Anxiety, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07296939: Recruiting NA study of Depression, Anxiety, sponsored by Florida State University.

NCT07296939 is a NA study of Depression, Anxiety that is actively recruiting participants, run by Florida State University. The registered enrollment target is 500 participants, above the 412-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07296939, a NA study of Depression, Anxiety, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.

Primary Outcome

Clinician-rated assessment of overall clinical change, with scores ranging from 1 (very much improved) to 7 (very much worse).

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2026-02
Est. Completion 2026-07-31
Phase NA
Florida State University

219 total trials

What NCT07296939 shows while recruiting

NCT07296939 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 412-participant average among 40 other Depression, Anxiety trials with a reported enrollment target (21% higher).

The record links to 1 condition, with Depression, Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT07296939 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07296939 about?

NCT07296939 is a clinical study titled "Youth Emotional and Behavioral Treatment Study". This study aims to characterize key mechanisms underlying the development, maintenance, and treatment of severe irritability in a clinically heterogeneous sample of school-aged youth.

What is the current status of trial NCT07296939?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-02. Estimated completion is 2026-07-31.

What conditions does trial NCT07296939 study?

This clinical trial studies the following conditions: Depression, Anxiety.

What interventions are being tested in trial NCT07296939?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07296939?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07296939 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression, Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07296939's enrollment target sits among peer trials

500 6th of 40 higher than 35 of 40 other Depression, Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression, Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07296939, the US trial registry maintained by the National Library of Medicine. NCT07296939 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.